Daklinza

Daklinza is an antiviral drug that has as active substance Daclatasvir, which helps fight the virus that causes the onset of hepatitis C.

Daklinza is produced by Bristol-Myers Squibb Pharma and can be purchased from conventional pharmacies in the form of tablets for oral use.

Indications of the Daklinza

Daklinza is indicated for the treatment of hepatitis C in adults.

How to use the Daklinza

The mode of use of Daklinza consists of the ingestion of 1 tablet of 60mg per day, between 14 to 24 weeks, according to your doctor's appointment.

Daklinza side effects

The most common side effects of Daklinza include headache, nausea, tiredness, loss of appetite, difficulty sleeping, dizziness, migraine, shortness of breath, heartburn, skin changes and diarrhea.

Contraindications of Daklinza

Daklinza is contraindicated for people who are allergic to any substance in the formula, as well as to patients receiving Phenytoin, Carbamazepine, Oxcarbazepine, Phenobarbital, Rifampin, Rifabutin, Rifapentin, Dexamethasone or who use Hypericum medicines in their composition.

Useful links:

• Symptoms of Hepatitis C
• Hepatitis C has a cure
• Hepatitis C